| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3392601 | Transplant Immunology | 2006 | 6 Pages |
Abstract
Our results suggest that the modified donor-reactive ELISPOT approach might provide a useful surrogate marker for renal transplant outcome with possible utility especially in T-lymphopenic patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Bele Johanna Näther, Peter Nickel, Gantuja Bold, Franziska Presber, Constanze Schönemann, Johann Pratschke, Hans-Dieter Volk, Petra Reinke,